Air Liquide enters Saudi Arabia’s Home Healthcare market

With the acquisition of the respiratory division of Thimar Al Jazirah Company (TAC) in Saudi Arabia, Air Liquide enters the Home Healthcare market in the Kingdom, and expands its Healthcare activity in the Middle East.

TAC是沙特阿拉伯王国制药，医疗和牙科行业领先的演员（KSA）。通过多数股权（60％）收购，TAC家庭医疗保健部门专注于分销respiratory equipment和睡眠障碍诊断服务for patients suffering from respiratory conditions(sleep apnea, ventilation, chronic respiratory failure). TAC is the main player in this field in Saudi Arabia,serving over 1,400 patients at homethroughout the country. The Home Healthcare division of TAC generated a revenue of over€5.5 million2016年。

This acquisition reinforces the healthcare position of Air Liquide in Saudi Arabia, where it already supplies medical gases to hospitals. It also representsthe entry into a territory with high potential for Air Liquide's Home Healthcare activity。收购实体已加入VitalAire，Air Liquide的家庭医疗保健品牌。

With a population of over 32 million, rising healthcare needs and a commitment from public authorities to improve the quality of healthcare services in the Kingdom, the healthcare sector in KSA presents a strong potential with notably an increasing opening to foreign investors driven by theSaudi government’s 2030 Vision。

Françoisjackow，航空液化银行集团执行委员会的成员，监督医疗保健活动，说：“通过此次收购，Air Liquide在沙特阿拉伯开发其活动，并在中东扩大其医疗保健业务。我们欢迎新的TAC员工到液化空气的运营，并期待为沙特阿拉伯患者带来高质量的服务和一流的创新，因为我们每天为世界各地的超过140万患者所做的。”